Conduit Pharmaceuticals Inc.
13F holders, Q1 2025 (March 31)1holders −40
1new positions
41sold out
$0.05avg. 13F price*
At the end of Q1 2025, 1 institutions reported holding Conduit Pharmaceuticals Inc. in their 13F filings, down 40 from Q4 2024. 1 opened new positions and 41 sold out. The largest holder was IFP Advisors, Inc ($904).
- Company
- Conduit Pharmaceuticals Inc.
- CUSIP
- 20678X106
- Latest filing quarter
- Q1 2025
History
Number of 13F holders
Total Exit/New Position Q4 2024 → Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $904 |
| Exits | 41 | $599K |
All 13F filers, Q4 2024 → Q1 2025: 20,000 shares bought and 8,734,838 shares sold, net −8,714,838 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 1 holders
| IFP Advisors, Inc | 0.00% | New | 20,000 | $904 |
"% of holder's portfolio" is CONDUIT PHARMACEUTICALS INC's weight in each manager's 13F, not the share of Conduit Pharmaceuticals Inc. the manager owns.